109
Participants
Start Date
March 1, 2022
Primary Completion Date
March 29, 2023
Study Completion Date
December 30, 2026
Fenebrutinib
Fenebrutinib will be administered orally.
Placebo
Placebo will be administered orally.
Klinicki bolnicki centar Zagreb, Zagreb
Poliklinika Solmed, Zagreb
Clinical Center of Serbia, Belgrade
Military Medical Academy, Belgrade
Clinical Hospital Centre Zemun, Zemun
Clinical Center Nis, Niš
Clinical center Kragujevac, Kragujevac
General Hospital Varazdin, Varaždin
Clinical Hospital Center Rijeka - PPDS, Rijeka
Nemocnice Jihlava, Jihlava
University Clinical Centre of the Republic of Srpska, Banja Luka
Cleveland Clinic Lou Ruvo, Las Vegas
Fullerton Neurology and Headache Center, Fullerton
Fakultni nemocnice u sv. Anny v Brne, Brno
Fakultni nemocnice Hradec Kralove, Hradec Králové
Vseobecna Fakultni Nemocnice V Praze - CRC - PPDS, Prague
Univerzitna nemocnica Bratislava, Bratislava
Hoffmann-La Roche
INDUSTRY